Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Broker-dealer MF Global to realign priorities, reduce staff

Wednesday, September 14, 2011
Opalesque Industry Update - MF Global Holdings Ltd., a broker-dealer providing trading and hedging solutions, is rearranging its global Equities business and focusing on areas where it is at its strongest, namely commodities, financial services, consumer and global policy research.

Consequently, MF will reduce staff in equity sales, sales trading and research in Europe and Asia by more than 30%, according to a release issued today. And the company will enhance its presence in commodities and global policy research capabilities and the sales, trading and client facilitation activities to support these sectors throughout Asia and Europe.

MF delivers trading and hedging solutions across all major global markets; Commodities, Equities, Fixed Income, Foreign Exchange, and Futures & Options.

"MF Global has a long history of leadership and expertise in derivatives and commodities as well as strong global policy perspective that we gained through the acquisition of Washington Research Group in 2010," said Peter Forlenza, global head of Equities at MF Global.

“This realignment is part of the company's ongoing transformation to a commodities-focused investment bank,” he added.


As a defendant in a U.S. court, MF Global together with former veteran Moore trader Christopher Pia won the dismissal of claims that they had conspired with hedge fund Moore Capital to fix prices on platinum and palladium futures contracts in 2007-2008, Reuters reported on Sept. 13th, 2011.

The firm raised controversies in August when it announced a $300m underwritten public offering of senior unsecured debt subject to market conditions and other factors. The "Key Man Event" clause in the bonds’ prospectus promised additional compensation for investors who buy the company’s bonds with an interest-rate bump if its Chairman and CEO Jon Corzine accepts a job in Washington as part of President Barack Obama’s team (see Opalesque article). No news of him taking such a job so far, but we heard two weeks later that Corzine had bought 18,800 shares of MF on at an average price of $5.25 a share.
B. Gravrand

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for